Healx secures $47m to advance AI-driven rare disease treatments
Genetic Engineering & Biotechnology News (GEN) - 01-Aug-2024The UK-based company prepares for clinical trials with its innovative NF1 drug, HLX-1502
Join the club for FREE to access the whole archive and other member benefits.
Senior editor at Genetic Engineering & Biotechnology News (GEN)
Uduak joined GEN as a senior editor in 2023 after working as a consulting science writer and editor. Previously, she was a writer and editor for a New York City-based think tank and an editor at GenomeWeb, where she covered bioinformatics and computational biology trends in industry and academia for several years. Her work has also appeared in IEEE Bits Magazine. She holds a BA from Calvin University and an MA from New York University.
Visit website: https://www.genengnews.com/author-archive/?author-id=32040
See also
News provider in the fields of biotechnology and genetic engineering
Details last updated 12-Feb-2025
The UK-based company prepares for clinical trials with its innovative NF1 drug, HLX-1502